QQ客服 官方微博 反馈留言

浏览/检索结果: 共13条，第1-10条 帮助 限定条件 专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients 期刊论文 2019, 卷号: 111, 期号: 1, 页码: 86-94 作者:  Lambertini, Matteo;  Campbell, Christine;  Bines, Jose;  Korde, Larissa A.;  Izquierdo, Miguel 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4) 期刊论文 2018, 卷号: 29, 期号: 8, 页码: 1634-1657 作者:  Cardoso, F.;  Senkus, E.;  Costa, A.;  Papadopoulos, E.;  Aapro, M. 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03 breast cancer  metastatic  advanced  guidelines  ABC  ESO-ESMO   Adjuvant anti-HER2 therapy, treatment-induced amenorrhea (TIA) and survival in premenopausal patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Analysis from the ALTTO trial (BIG 2-06) 会议论文 ANNALS OF ONCOLOGY, 2017-09-01 作者:  Lambertini, M.;  Campbell, C.;  Bines, J.;  Korde, L.;  Delso, M. A. Izquierdo 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 IMpassion131: Phase III study comparing 1L atezolizumab with paclitaxel vs placebo with paclitaxel in treatment-naive patients with inoperable locally advanced or metastatic triple negative breast cancer (mTNBC) 会议论文 ANNALS OF ONCOLOGY, 2017-09-01 作者:  Miles, D.;  Andre, F.;  Gligorov, J.;  Verma, S.;  Xu, B. 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/03 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) 期刊论文 2017, 卷号: 28, 期号: 1, 页码: 16-33 作者:  Cardoso F;  Costa A;  Senkus E;  Aapro M;  André F 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 Adjuvant anti-HER2 therapy, treatment-induced amenorrhea (TIA) and survival in premenopausal patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Analysis from the ALTTO trial (BIG 2-06) 期刊论文 2017, 卷号: 28 作者:  Lambertini, M.;  Campbell, C.;  Bines, J.;  Korde, L.;  Delso, M. A. Izquierdo 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 IMpassion131: Phase III study comparing 1L atezolizumab with paclitaxel vs placebo with paclitaxel in treatment-naive patients with inoperable locally advanced or metastatic triple negative breast cancer (mTNBC) 期刊论文 2017, 卷号: 28 作者:  Miles, D.;  Andre, F.;  Gligorov, J.;  Verma, S.;  Xu, B. 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/03 Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease 期刊论文 2017, 卷号: 377, 期号: 14, 页码: 1319-1330 作者:  Eikelboom, J. W.;  Connolly, S. J.;  Bosch, J.;  Dagenais, G. R.;  Hart, R. G. 收藏  |  浏览/下载：62/0  |  提交时间：2020/01/03 Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259 期刊论文 2017, 卷号: 32, 页码: 269-270 作者:  Cardoso F;  Costa A;  Senkus E;  Aapro M;  André F 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04 Updated results from the phase III ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T -> L) or their combination (L plus T) in the adjuvant tre 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20 作者:  Moreno-Aspitia, Alvaro;  Holmes, Eileen McCormick;  Jackisch, Christian;  De Azambuja, Evandro;  Boyle, Frances M. 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04